Articles published in Journal of Diabetes & Metabolism have been cited by esteemed scholars and scientists all around the world. Journal of Diabetes & Metabolism has got h-index 43, which means every article in Journal of Diabetes & Metabolism has got 43 average citations.
Following are the list of articles that have cited the articles published in Journal of Diabetes & Metabolism.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Year wise published articles |
107 | 59 | 61 | 45 | 23 |
Year wise citations received |
869 | 844 | 899 | 793 | 852 |
| Journal total citations count | 9622 |
| Journal impact factor | 12.50 |
| Journal 5 years impact factor | 18.23 |
| Journal cite score | 23.62 |
| Journal h-index | 43 |
| Journal h-index since 2018 | 28 |
| Journal Impact Factor 2020 formula |
| IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year |
| Journal 5-year Impact Factor 2020 formula |
| Citations(2016 + 2017 + 2018 + 2019 + 2020)/ {Published articles(2016 + 2017 + 2018 + 2019 + 2020)} |
| Journal citescore |
| Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3 |
Xu X, Wang G, Zhou T, Chen L, Chen J, et al. (2014) Novel approaches to drug discovery for the treatment of type 2 diabetes. Expert opinion on drug discovery 9: 1047-1058. |
|
Vatandoost N, Amini M, Iraj B, Momenzadeh S, Salehi R (2015) Dysregulated miR-103 and miR-143 expression in peripheral blood mononuclear cells from induced prediabetes and type 2 diabetes rats. Gene 572: 95-100. |
|
DeMenna J, Puppala S, Chittoor G, Schneider J, Kim JY, et al. (2014) Association of common genetic variants with diabetes and metabolic syndrome related traits in the Arizona Insulin Resistance registry: a focus on Mexican American families in the Southwest. Human heredity 78: 47-58. |
|
Pae EK, Ahuja B, Kim M, Kim G (2013) Impaired glucose homeostasis after a transient intermittent hypoxic exposure in neonatal rats. Biochemical and biophysical research communications 441: 637-642. |
|
Van Leeuwen N, Swen JJ, Guchelaar HJ (2013) The role of pharmacogenetics in drug disposition and response of oral glucose-lowering drugs. Clinical pharmacokinetics 52: 833-854. |
|
Zhao Q, Xiao J, He J, Zhang X, Hong J, et al. (2014) Cross-sectional and longitudinal replication analyses of genome-wide association loci of type 2 diabetes in Han Chinese. PloS one 9: e91790. |
|
Safavi M, Foroumadi A, Abdollahi M (2013) The importance of synthetic drugs for type 2 diabetes drug discovery. Expert opinion on drug discovery 8: 1339-1363. |
|
Emamiâ€Riedmaier A, Schaeffeler E, Nies AT, Mörike K, Schwab M (2015) Stratified medicine for the use of antidiabetic medication in treatment of type II diabetes and cancer: where do we go from here?. Journal of internal medicine 277: 235-247. |
|
Almawi WY, Nemr R, Keleshian SH, Echtay A, Saldanha FL, et al. (2013) A replication study of 19 GWAS-validated type 2 diabetes at-risk variants in the Lebanese population. Diabetes research and clinical practice 102: 117-122. |
|
Go MJ, Hwang JY, Park TJ, Kim YJ, Oh JH, et al. (2014) Genome-wide association study identifies two novel Loci with sex-specific effects for type 2 diabetes mellitus and glycemic traits in a korean population. Diabetes & metabolism journal 38: 375-387. |
|
Glauber HS, Rishe N, Karnieli E (2014) Introduction to personalized medicine in diabetes mellitus. Rambam Maimonides Med J 5: e0002. |
|
Wali JA, Thomas HE, Sutherland AP (2014) Linking obesity with type 2 diabetes: the role of T-bet. Diabetes, metabolic syndrome and obesity: targets and therapy 7: 331. |
|
Kamstrup PR, Nordestgaard BG (2013) Lipoprotein (a) concentrations, isoform size, and risk of type 2 diabetes: a Mendelian randomisation study. The Lancet Diabetes & Endocrinology 1: 220-227. |
|
Torres JM, Cox NJ, Philipson LH (2013) Genome wide association studies for diabetes: perspective on results and challenges. Pediatric diabetes 14: 90-96. |
|
Torres JM, Gamazon ER, Parra EJ, Below JE, Valladares-Salgado A, et al. (2014) Cross-tissue and tissue-specific eQTLs: partitioning the heritability of a complex trait. The American Journal of Human Genetics 95: 521-534. |
|
Talmud PJ, Cooper JA, Morris RW, Dudbridge F, Shah T, et al. (2014) Sixty-five common genetic variants and prediction of type 2 diabetes. Diabetes. |
|
Wu Y, Ding Y, Tanaka Y, Zhang W (2014) Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. International journal of medical sciences 11: 1185. |
|
Dash RP, Babu RJ, Srinivas NR (2016) Comparative pharmacokinetics of three SGLT-2 inhibitors sergliflozin, remogliflozin and ertugliflozin: an overview. Xenobiotica 28: 1-2. |
|
Devineni D, Manitpisitkul P, Murphy J, Skee D, Wajs E, et al. (2015) Effect of canagliflozin on the pharmacokinetics of glyburide, metformin, and simvastatin in healthy participants. Clinical pharmacology in drug development 4: 226-236. |
|
Sigafoos JF, Bowers GD, Castellino S, Culp AG, Wagner DS, et al. (2012) Assessment of the drug interaction risk for remogliflozin etabonate, a sodium-dependent glucose cotransporter-2 inhibitor: evidence from in vitro, human mass balance, and ketoconazole interaction studies. Drug Metabolism and Disposition 40: 2090-2101. |
|
